Interestingly, rs2523608 has been reported to be negatively associated with the binding antibody response to interferon beta-1a (IFN beta-1a) therapy in multiple sclerosis (MS), which shares common pathogenic processes with CD52. Here, CD52 is linked to multiple sclerosis.